Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Niban apoptosis regulator 1 (NIBAN1) is a protein encoded by the NIBAN1 gene (formerly FAM129A/C1orf24) on chromosome 1q25.3. It belongs to the family with sequence similarity 129 (FAM129), sharing a pleckstrin homology (PH) domain in its N-terminal region. NIBAN1 is highly expressed in multiple cancer types and some normal tissues, especially under stress conditions, where it participates in regulating key processes such as apoptosis (including p53-mediated events), cell proliferation, survival under cellular stress, and autophagy. NIBAN1 is implicated in several cancer types and is being explored as a diagnostic and/or prognostic biomarker, particularly because its expression increases during early carcinogenesis in tissues like kidney and thyroid. Though it is often referred to as a "regulator" in biological stress responses, NIBAN1 is not a classical drug target such as a receptor, enzyme, or transporter, and there are currently no known drugs that directly target it[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Niban apoptosis regulator 1 (NIBAN1).